Calendar of Events & Lectures

Today
This Week

Tuesday, March 28, 2017

Systems Biology of the Type I Interferon Response

| 305 WRB
Seminars, Other Seminars
Paul Hertzog, Ph.D., professor and NHMRC Senior Principal Research Fellow, Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Australia

Protein Interaction Studies of Receptor Tyrosine Kinases Using MaMTH, a Novel Proteomic Approach: Toward Interactome-informed Medicine

| AUDITORIUM, ROCKEFELLER RESEARCH LABORATORIES, MSKCC, 430 E. 67TH ST.
Tri-Institutional Events (at MSK & WCM), Other Tri-Institutional Events
Igor Stagljar, Ph.D., professor, department of biochemistry and department of molecular genetics, University of Toronto

Inaugural Peter H. Sellers Lecture

| CARSON FAMILY AUDITORIUM (CRC)
Seminars, Center for Studies in Physics and Biology Seminars
Dirichlet Mixtures, the Dirichlet Process, and the Topography of Amino Acid Multinomial Space
Stephen F. Altschul, Ph.D., senior investigator, National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health

Tri-Institutional Calendars

The close proximity among the three institutions which comprise the Tri-I has led to a culture that encourages interinstitutional interactions and shared resources, including access to lectures and seminars from internationally renowned scientists and clinicians:

Upcoming Events

Microscale Biophysics of the Ocean: A Single-Cell Perspective on the Biological Carbon Pump

| CARSON FAMILY AUDITORIUM (CRC)

Liquid Biopsies in Pediatric Solid Tumors

| CARSON FAMILY AUDITORIUM (CRC)

Spying on the Immune System

| CASPARY AUDITORIUM
The Philip Levine Memorial Lecture

News

Some mammals can hit pause on a pregnancy. Understanding how that happens could help us treat cancer.

New study reveals the molecular brake that lets embryonic stem cells enter suspended animation, while retaining the ability to develop normally—which could shed light on abnormal cell growth in humans.

New engineered derivative of a natural molecule could translate into a powerful replacement for IVIG therapy for a wide array of autoimmune disorders

In experiments with mice, the new molecule accomplished the same job at a hundredth of the dose.

This new insight into T cell receptors may improve cancer immunotherapies

Researchers discovered that a crucial first step in the signaling system operates differently than previously thought, an insight that could lead to the next generation of treatments.

Room Reservation Calendar